New COVID-19 drug, remdesivir, which is under clinical trial may reduce the sperm count in mice, a preliminary finding by Chinese researchers reveal.
The drug manufactured by Gilead Sciences Inc. was injected into 28 males and their sperm count and motility became low, according to the study conducted by Shenzhen Maternity and Child Healthcare Hospital and Shenzhen Second People’s Hospital showed.
The study has not been peer reviewed, but was published on the biology pre-print website operated by Cold Spring Harbor Laboratory.
Meanwhile, China said it plans to announce the results from the clinical tests which was conducted in Wuhan on Monday
Listen to top Radio Stations in Abia State CLICK HERE
Support Afnews Independent Journalism
At Afnews, we are dedicated to providing accurate, insightful, and timely news coverage. Our commitment to journalistic integrity ensures that you receive trustworthy information, unfiltered and unbiased. To maintain our independence and continue delivering quality content, we rely on the support of our readers.
If you value the work we do, please consider making a contribution. Your support enables us to keep bringing you the stories that matter.
Donate today and help us keep independent journalism alive. Thank you for your support!
